| Sumario: | Part of a special issue on sequestered science and the consequences of undisclosed knowledge. The writer discusses the legal clash between researchers and their sponsors over disclosure of the findings of the clinical trials of Remune, an AIDS therapy developed by California biotech company Immune Response Corporation. She presents an outline of what science is and does that implies how and why the manner in which scientific work is funded can distort or even impede its progress. She applies this theory to an analysis of the troubled history of the trials, clinical and legal, of Remune. Finally, she offers some thoughts on industrial sponsorship of scientific research in the universities.
|
|---|